المؤلفون: Liubov I. Kozlovskaya (11413365), Anastasia N. Piniaeva (11413368), Georgy M. Ignatyev (11413371), Ilya V. Gordeychuk (2826434), Viktor P. Volok (11413374), Yulia V. Rogova (400814), Anna A. Shishova (11413377), Anastasia A. Kovpak (11413380), Yury Yu. Ivin (11413383), Liliya P. Antonova (11413386), Kirill M. Mefyod (11413389), Lyubov S. Prokosheva (11413392), Anna S. Sibirkina (11413395), Yuliya Yu. Tarasova (11413398), Ekaterina O. Bayurova (11413401), Olga S. Gancharova (6178112), Victoria V. Illarionova (11413404), Grigory S. Glukhov (11413407), Olga S. Sokolova (4390033), Konstantin V. Shaitan (597724), Anastasia M. Moysenovich (6039092), Stanislav A. Gulyaev (11413410), Tatiana V. Gulyaeva (11413413), Andrey V. Moroz (11413416), Larissa V. Gmyl (11413419), Elena G. Ipatova (11413422), Mikhail P. Kirpichnikov (472252), Alexey M. Egorov (11413425), Aleksandra A. Siniugina (11413428), Aydar A. Ishmukhametov (9592899)

مصطلحات موضوعية: Medicine, Genetics, Neuroscience, Immunology, Cancer, Infectious Diseases, Vaccine, SARS-CoV-2, COVID-19, neutralizing antibodies, safety, immunogenicity, inactivated vaccine, preclinical study

Relation: https://figshare.com/articles/journal_contribution/Long-term_humoral_immunogenicity_safety_and_protective_efficacy_of_inactivated_vaccine_against_COVID-19_CoviVac_in_preclinical_studies/16595382

الاتاحة: https://doi.org/10.6084/m9.figshare.16595382.v1

المؤلفون: Maria Yu. Zakharova (11797175), Alexandra A. Kuznetsova (9582740), Victoria I. Uvarova (11797178), Anastasiia D. Fomina (11797181), Liubov I. Kozlovskaya (11413365), Elena N. Kaliberda (11797184), Inna N. Kurbatskaia (11797187), Ivan V. Smirnov (7753151), Anatoly A. Bulygin (11797190), Vera D. Knorre (11797193), Olga S. Fedorova (24654), Alexandre Varnek (1425595), Dmitry I. Osolodkin (9089678), Aydar A. Ishmukhametov (9592899), Alexey M. Egorov (11413425), Alexander G. Gabibov (350318), Nikita A. Kuznetsov (24651)

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, SARS-CoV-2, main protease, pre-steady-state kinetics, substrate cleavage, inhibitor binding, molecular docking, stopped-flow

Relation: https://figshare.com/articles/dataset/DataSheet1_Pre-Steady-State_Kinetics_of_the_SARS-CoV-2_Main_Protease_as_a_Powerful_Tool_for_Antiviral_Drug_Discovery_docx/17129591

الاتاحة: https://doi.org/10.3389/fphar.2021.773198.s001